Business Wire

NC-LENOVO

27.10.2021 06:03:09 CEST | Business Wire | Press release

Share
Lenovo Launches the Kind City: Interactive Global Collaboration Encourages Empathy and Creates a Future Built on Kindness

Today, Lenovo ™ (HKSE: 992) (ADR: LNVGY) launches the Kind City project —a vision to change urban environments forever and create future cities built on kindness.

By championing empathy in society, the project strives to encourage stronger, more inclusive communities made possible through smarter technology, and restore kindness in places where citizens feel increasingly disconnected.

Lenovo’s Kind City is the biggest crowdsourced public ‘census’ to imagine and co-author a blueprint for a city of the future built on kindness. It’s mission? To bring a more empathetic future to life through insight from global research, a public invitation to participate, and an interactive podcast featuring city dwellers and some of the world’s brightest minds.

“We believe the Kind City project will be the blueprint for mapping a kinder and better future,” said John Gordon, President of Industry Solutions at Lenovo. “Technology can and will make the future kinder, more inclusive, and more equitable. In cities, this means providing smarter technology for all—across socio-economic or cultural backgrounds—including both devices and solutions.”

Kind Council Formation and Interactive Podcast

Bringing together leading thinkers and global experts in their fields, Lenovo’s Kind City is steered by a panel of world-renowned visionaries who make up the project’s “Kind Council.” This includes British-American fashion designer and philanthropist Tan France, 2020 TIME Kid of the Year and inventor Gitanjali Rao, Brazilian rapper Emicida, UK robotics scientist Dr. Peter Scott-Morgan, German futurologist Oona Strathern, and Japanese author and entrepreneur Ibun Hirahara.

The group has collaborated on a choose-your-own-path podcast to discuss the fundamentals in achieving a Kind City, such as inclusion, trust, sustainability, dreams, and opportunity.

As the backbone of the entire initiative, the innovative podcast also explores powerful conversations and incredible stories with voices less commonly heard in futurism. Listeners can navigate from multigenerational living in the USA, to climate change in China, to tech hubs in Brazilian favelas, to dream research in the UK and a kindness currency in Japan.

The insightful and interactive podcast encourages listeners to become part of the discussion while giving them the opportunity to navigate an audio journey personalised to their interests. More than 20 stories, discussions, and interviews were captured from across the globe, from the United States and Germany to Japan and Brazil.

The podcast features NGO and charity partners from around the world, showcasing their efforts to support city residents. Lenovo will work directly with these organizations over the coming months and identify the most impactful ways to collaborate, from workshops on technology solutions with Lenovo experts, to device donations and financial support.

Major New Research Uncovers the ‘Kindness Gap’

The Kind City project comes on the heels of fresh research conducted by Lenovo that dives deep into the lives of city dwellers and their perspectives on the quality of life in their current cities.

Surveying more than 5,000 city dwellers across five countries (Brazil, Germany, Japan, United Kingdom, United States), the study exposes the growing need for society to rethink how we live together in city centers post-pandemic.

Research revealed traditional organizations and government are falling short on prioritizing kindness, leaving it to local neighborhoods and communities to shoulder more than their share of the responsibility.

Ultimately a major ‘Kindness Gap’ exists globally in cities with 97% of all polled believing it is important their communities have kindness/empathy, but only 37% feeling their current city is a kind place to live or work.

While the study finds respondents have a somewhat positive impression of the quality of life where they live, they also draw a clear connection between greater kindness in their cities and many tangible benefits, for example, improved mental and physical health; feelings of inclusivity and pride; greater enjoyment and flexibility, that could unlock even happier lifestyles. A significant opportunity for improvement in the face of these challenges exists, including:

  • Most respondents (55%) believe the quality of life in their city is either not getting better or staying the same. In cities across the globe, majorities say that there is room for improvement in their general living and working conditions.

  • City residents have reservations about how much the officials that represent them consider kindness when making decisions for the city. Less than one in five (17%) believe their policymakers strongly consider kindness and empathy when it comes to their city.

  • Most residents think technology will be a pivotal solution (83%) for promoting and employing kindness in their cities, most notably in Brazil (88%).

What the kindness gap presents is a real opening to the private sector to enable and empower greater kindness and empathy. More than ever, there’s an urgency to work toward a more equitable future—and we can use the power of technology to make this come to fruition.

Get Involved: Become a Kind City Citizen

The initiative is calling upon people from all walks of life, across every major city to voice their vision of what a kinder city should be.

Lenovo invites the general public to share their personal vision of an empathetic and inclusive community by becoming Kind City citizens, which they can do by simply completing the following statement: “The future of the Kind City will…” on Lenovo’s microsite housing the project KindCity.com .

All responses received through November 15 will be curated using AI and transformed into 10 founding principles. These will be shared across the world through a range of exciting installations and experiential initiatives. Lenovo will also reveal details of collaborations with the global NGOs featured in the podcast, with actions shaped by Kind City submissions and research.

About Lenovo

Lenovo (HKSE: 992) (ADR: LNVGY) is a US$60 billion revenue Fortune Global 500 company serving customers in 180 markets around the world. Focused on a bold vision to deliver smarter technology for all, we are developing world-changing technologies that power (through devices and infrastructure) and empower (through solutions, services and software) millions of customers every day and together create a more inclusive, trustworthy and sustainable digital society for everyone, everywhere. To find out more visit https://www.lenovo.com and read about the latest news via our StoryHub .

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye